M — Myriad Uranium Income Statement
0.000.00%
- CA$17.64m
- CA$14.66m
Annual income statement for Myriad Uranium, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.141 | 0.276 | 0.338 | 1.48 | 3.71 |
Operating Profit | -0.141 | -0.276 | -0.338 | -1.48 | -3.71 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.14 | -0.273 | -0.331 | -1.5 | -3.68 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.14 | -0.273 | -0.331 | -1.5 | -3.68 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.14 | -0.273 | -0.331 | -1.5 | -3.68 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.14 | -0.273 | -0.331 | -1.5 | -3.68 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.028 | -0.03 | -0.013 | -0.068 | -0.071 |